SPYRE THERAPEUTICS, INC. Increase (Decrease) in Restricted Cash
SPYRE THERAPEUTICS, INC. (SYRE) reported Increase (Decrease) in Restricted Cash of -$80.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2019-03-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2019-03-07
- SPYRE THERAPEUTICS, INC. increase (decrease) in restricted cash for the quarter ending 2016-12-31 was $0.00.
- SPYRE THERAPEUTICS, INC. increase (decrease) in restricted cash for the quarter ending 2015-12-31 was $0.00.
- SPYRE THERAPEUTICS, INC. increase (decrease) in restricted cash for fiscal 2016 was -$80.00K, a 300.00% decline from fiscal 2015.
- SPYRE THERAPEUTICS, INC. increase (decrease) in restricted cash for fiscal 2015 was $40.00K, a 0.00% change from fiscal 2014.
- SPYRE THERAPEUTICS, INC. increase (decrease) in restricted cash for fiscal 2014 was $40.00K.
| Period end | Increase (Decrease) in Restricted Cash 3 month | Increase (Decrease) in Restricted Cash 9 month | Increase (Decrease) in Restricted Cash 12 month |
|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | -$80.00K 10-K · filed 2019-03-07 | |
| 2016-09-30 | -$80.00K 10-Q · filed 2016-11-09 | ||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | $40.00K 10-K · filed 2018-03-13 | |
| 2015-09-30 | $40.00K 10-Q · filed 2016-11-09 | ||
| 2014-12-31 | $40.00K 10-K · filed 2017-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |